ITGRNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Integer Holdings Corp

Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 4, 2026

$126.75+0.05 (+0.04%)

Close on Oct 19, 2026

Market cap: $4.33B
P/E (TTM): 34.6
Dividend yield: –

Integer Holdings Corp income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-28	FY 2017 2017-12-29	FY 2016 2016-12-30	FY 2015 2016-01-01	FY 2014 2015-01-02	FY 2013 2014-01-03	FY 2012 2012-12-28	FY 2011 2011-12-30	FY 2010 2010-12-31	FY 2009 2010-01-01
Revenue	1,854	1,717	1,556	1,331	1,221	1,073	1,258	1,215	1,136	1,076	800	688	664	646	569	533	522
Cost of Revenue	1,353	1,258	1,146	986	884	788	903	852	782	738	565	456	445	445	388	360	355
Gross Profit	500	459	410	346	337	286	355	363	354	338	235	231	219	202	180	174	166
Research & Development	49	53	62	60	52	48	47	49	49	48	53	50	54	52	46	45	34
Selling, General & Admin	212	185	173	158	141	109	139	142	143	136	103	91	88	81	73	65	70
Operating Expenses	279	251	247	233	201	165	197	207	228	245	222	156	158	176	119	105	165
Operating Income	221	208	163	113	136	121	158	156	126	93	13	76	61	26	62	69	1.05
Interest Expense	43	56	51	37	32	38	53	99	64	68	34	4.25	11	18	17	19	20
Interest & Investment Income	–	–	–	–	–	–	–	–	–	–	–	–	0	0.00	0.02	0.01	0.32
Income from Equity Investments	0.55	-0.53	-0.48	-7.64	-3.06	5.71	1.10	5.62	-3.69	-0.74	4.70	1.20	-0.20	-0.30	–	–	–
Other Non-Operating Income	-53	-3.52	-0.98	0.90	0.12	-1.52	0.58	-0.75	-11	4.41	1.32	0.81	-0.55	–	–	–	–
Merger & Restructuring Charges	2.28	4.01	5.87	4.01	4.80	3.72	–	–	–	–	–	–	–	–	–	–	–
Asset Impairment Charges	–	–	–	–	–	–	–	–	0.30	0.20	0	0.40	–	–	–	–	–
Gain (Loss) on Sale of Assets	0.05	0.18	0	0	0	0	4.97	195	0	0	–	–	–	–	–	–	–
Legal Settlements	–	–	–	–	–	28	–	–	–	–	0	–	–	0	0	9.50	–
Pretax Income	125	148	105	69	101	86	105	61	49	28	-16	77	49	6.73	48	49	-18
Income Tax Expense	23	27	16	8.93	8.04	8.95	14	14	-38	3.29	-8.11	21	13	12	15	16	-9.18
Income from Continuing Operations	103	121	89	60	93	77	91	47	87	25	–	–	–	–	–	–	–
Income from Discontinued Operations	-0.02	-1.16	1.51	6.63	3.79	0	5.12	121	-20	-19	–	–	–	–	–	–	–
Net Income	103	120	91	66	97	77	96	168	67	5.96	-7.59	55	36	-4.80	33	33	-9.00
Net Income to Common	–	–	–	–	–	–	–	–	67	5.96	-7.59	55	36	-4.80	33	33	–
EPS (Basic)(per share)	2.96	3.57	2.72	2.00	2.93	2.35	2.95	5.23	2.12	0.19	-0.29	2.23	1.51	-0.20	1.42	1.44	-0.39
EPS (Diluted)(per share)	2.89	3.36	2.69	1.99	2.91	2.33	2.92	5.15	2.08	0.19	-0.29	2.14	1.43	-0.20	1.40	1.40	-0.39
Shares Outstanding (Basic, Weighted)(shares)	35	34	33	33	33	33	33	32	31	31	26	25	24	24	23	23	23
Shares Outstanding (Diluted, Weighted)(shares)	36	36	34	33	33	33	33	33	32	31	26	26	25	24	24	24	23
EBITDA	352	319	262	205	217	200	236	245	228	183	58	113	97	72	98	105	48

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 3, 2026

Profitability, TTM

Gross margin: 25.7%
Operating margin: 9.7%
Net margin: 7.0%
Return on equity, FY2025: 6.1%

Financial strength

Current ratio: 3.73
Debt to equity: 0.72
Debt to assets: 36.2%
Cash to current liabilities: 9.8%

Valuation

P/E ratio: 34.6
Price to sales: 2.35
Price to book: 2.52
Dividend yield: –